Description
VA242-17-J-4162 - LAB TESTING - DECREASE PO
Base award description: IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING
Modification chain · 40 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-10-01+$2,784,000= $2,784,000
- Mod P000012018-03-29+$1,392,000= $4,176,000
- Mod P000022018-05-07+$22,293= $4,198,293
- Mod P000032018-05-07+$697= $4,198,991
- Mod P000042018-05-07-$42,527= $4,156,463
- Mod P000052018-06-25+$1,369,707= $5,526,170
- Mod P000062018-07-26+$26,443= $5,552,614
- Mod P000072018-09-19+$0= $5,552,614
- Mod P000082018-09-21+$75,000= $5,627,614
- Mod P000092018-09-21-$14,013= $5,613,600
- Mod P000102018-09-21-$26,791= $5,586,810
- Mod P000122018-10-01+$1,445,499= $7,032,308
- Mod P000132018-10-12+$711= $7,033,019
- Mod P000142018-11-02+$19,951= $7,052,970
- Mod P000152018-12-27+$1,893,000= $8,945,970
- Mod P000162019-02-06-$93,246= $8,852,724
- Mod P000192019-02-21-$27,586= $8,825,138
- Mod P000182019-02-22+$17,167= $8,842,304
- Mod P000172019-02-28+$86,760= $8,929,064
- Mod P000202019-02-28-$36,441= $8,892,623
- Mod P000212019-04-12+$113,900= $9,006,523
- Mod P000222019-04-12+$122,976= $9,129,499
- Mod P000232019-04-30-$220,000= $8,909,499
- Mod P000242019-04-30-$45,000= $8,864,499
- Mod P000252019-05-10+$6,260= $8,870,759
- Mod P000262019-05-10-$15,254= $8,855,505
- Mod P000272019-05-16-$94,307= $8,761,198
- Mod P000282019-05-16-$79,878= $8,681,321
- Mod P000292019-05-16-$8,647= $8,672,673
- Mod P000302019-07-03+$2,373= $8,675,046
- Mod P000312020-02-27-$3,896= $8,671,150
- Mod P000322020-02-27-$25,592= $8,645,558
- Mod P000332020-02-27-$125= $8,645,433
- Mod P000342020-03-04-$34,283= $8,611,150
- Mod P000352020-04-14-$15,076= $8,596,074
- Mod P000362020-04-14-$7,818= $8,588,255
- Mod P000372020-05-27-$146,934= $8,441,321
- Mod P000382020-05-27-$55,686= $8,385,635
- Mod P000392020-06-08-$4,603= $8,381,031
- Mod P000412021-11-26-$7,601= $8,373,430
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-10-01 | +$2,784,000 | $2,784,000 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00001· EXERCISE AN OPTION | 2018-03-29 | +$1,392,000 | $4,176,000 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-05-07 | +$22,293 | $4,198,293 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-05-07 | +$697 | $4,198,991 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-05-07 | −$42,527 | $4,156,463 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00005· EXERCISE AN OPTION | 2018-06-25 | +$1,369,707 | $5,526,170 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-07-26 | +$26,443 | $5,552,614 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-09-19 | +$0 | $5,552,614 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-09-21 | +$75,000 | $5,627,614 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-09-21 | −$14,013 | $5,613,600 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00010· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-09-21 | −$26,791 | $5,586,810 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00012· EXERCISE AN OPTION | 2018-10-01 | +$1,445,499 | $7,032,308 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-10-12 | +$711 | $7,033,019 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00014· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-11-02 | +$19,951 | $7,052,970 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00015· EXERCISE AN OPTION | 2018-12-27 | +$1,893,000 | $8,945,970 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00016· FUNDING ONLY ACTION | 2019-02-06 | −$93,246 | $8,852,724 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00019· FUNDING ONLY ACTION | 2019-02-21 | −$27,586 | $8,825,138 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00018· FUNDING ONLY ACTION | 2019-02-22 | +$17,167 | $8,842,304 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00017· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-02-28 | +$86,760 | $8,929,064 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00020· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-02-28 | −$36,441 | $8,892,623 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00021· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-04-12 | +$113,900 | $9,006,523 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00022· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-04-12 | +$122,976 | $9,129,499 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00023· FUNDING ONLY ACTION | 2019-04-30 | −$220,000 | $8,909,499 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00024· FUNDING ONLY ACTION | 2019-04-30 | −$45,000 | $8,864,499 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00025· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-05-10 | +$6,260 | $8,870,759 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00026· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-05-10 | −$15,254 | $8,855,505 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00027· FUNDING ONLY ACTION | 2019-05-16 | −$94,307 | $8,761,198 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00028· FUNDING ONLY ACTION | 2019-05-16 | −$79,878 | $8,681,321 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00029· FUNDING ONLY ACTION | 2019-05-16 | −$8,647 | $8,672,673 | IGF::CT::IGF INTERIM VISN LAB REFERENCE TESTING |
| Mod P00030· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-07-03 | +$2,373 | $8,675,046 | INTERIM VISN LAB REFERENCE TESTING |
| Mod P00031· FUNDING ONLY ACTION | 2020-02-27 | −$3,896 | $8,671,150 | INTERIM VISN LAB REFERENCE TESTING DECREASE/CLOSEOUT 620 PO# |
| Mod P00032· FUNDING ONLY ACTION | 2020-02-27 | −$25,592 | $8,645,558 | INTERIM VISN LAB REFERENCE TESTING DECEASE/CLOSEOUT 526 PO# |
| Mod P00033· FUNDING ONLY ACTION | 2020-02-27 | −$125 | $8,645,433 | INTERIM VISN LAB REFERENCE TESTING DECREASE/CLOSEOUT 526 PO# |
| Mod P00034· FUNDING ONLY ACTION | 2020-03-04 | −$34,283 | $8,611,150 | INTERIM VISN LAB REFERENCE TESTING DECREASE/CLOSEOUT PO# |
| Mod P00035· FUNDING ONLY ACTION | 2020-04-14 | −$15,076 | $8,596,074 | VA242-17-J-4162 - LAB TESTING - DECREASE PO |
| Mod P00036· FUNDING ONLY ACTION | 2020-04-14 | −$7,818 | $8,588,255 | VA242-17-J-4162 - LAB TESTING - DECREASE PO |
| Mod P00037· FUNDING ONLY ACTION | 2020-05-27 | −$146,934 | $8,441,321 | VA242-17-J-4162 - LAB TESTING - DECREASE PO |
| Mod P00038· FUNDING ONLY ACTION | 2020-05-27 | −$55,686 | $8,385,635 | VA242-17-J-4162 - LAB TESTING - DECREASE PO |
| Mod P00039· FUNDING ONLY ACTION | 2020-06-08 | −$4,603 | $8,381,031 | VA242-17-J-4162 - LAB TESTING - DECREASE PO |
| Mod P00041· FUNDING ONLY ACTION | 2021-11-26 | −$7,601 | $8,373,430 | VA242-17-J-4162 - LAB TESTING - DECREASE PO |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SXDFLBD5JFP3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25026N0525 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q301 · REFERENCE LABORATORY TESTING | $544,428 | FY2026 |
| 36C25026D0049 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2026 |
| 36C24226N0578 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · Q301 · REFERENCE LABORATORY TESTING | $10,500 | FY2026 |
| 36C24225N0529 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · Q301 · REFERENCE LABORATORY TESTING | $10,500 | FY2025 |
| 36C25725P0072 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $12,972 | FY2025 |
| 36C24224N0573 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · Q301 · REFERENCE LABORATORY TESTING | $1,955 | FY2024 |
Other recipients under Q301 from 242-NETWORK CONTRACT OFFICE 02 (36C242) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24226N0689 | CENTRAL TOX LLC | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $79,995 | FY2026 |
| 36C24226N0614 | LABORATORY CORPORATION OF AMERICA | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $2,352,838 | FY2026 |
| 36C24226A0050 | LABORATORY CORPORATION OF AMERICA | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $0 | FY2026 |
| 36C24226N0607 | QUEST DIAGNOSTICS INCORPORATED | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $675,002 | FY2026 |
| 36C24226N0524 | WYOMING COUNTY COMMUNITY HOSPITAL | 242-NETWORK CONTRACT OFFICE 02 (36C242) | $19,400 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24217J4162_3600_VA24217D0215_3600 · retrieved 2026-09-26.